Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Kube, Dianne ^a,b   Sontich, Ute ^a   Fletcher, David ^a   Davis, Pamela B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; Granulocyte macrophage colony stimulating factor; Inflammation; Interleukin 6; Interleukin 8

Indexed keywords

CYTOKINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; RANTES;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; T LYMPHOCYTE ACTIVATION;

EID: 0034997191     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l493     Document Type: Article

References (31)

1. Black HR, Yankaskas JR, Johnson LG, and Noah TL. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. Am J Respir Cell Mol Biol 19: 210-215, 1998.
2. Bryan R, Kube D, Perez A, Davis P, and Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol 19: 269-277, 1998.
3. Colotta F, Re F, Polentarutti N, Sozzani S, and Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80: 2012-2020, 1992.
4. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, and Gruenert DC. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47, 1994.
5. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, and Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 94: 13504-13509, 1997.
6. DiMango E, Ratner AJ, Bryan R, Tabibi S, and Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101: 2598-2605, 1998.
7. DiMango E, Zar HJ, Bryan R, and Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96: 2204-2210, 1995.
8. Eigen H, Rosenstein BJ, FitzSimmons S, and Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 126: 515-523, 1995.
9. Hull J and Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53: 1018-1021, 1998.
10. Imundo L, Barasch J, Prince A, and Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 92: 3019-3023, 1995.
11. Kammouni W, Figarella C, Marchand S, and Merten M. Altered cytokine production by cystic fibrosis tracheal gland serous cells. Infect Immun 65: 5176-5183, 1997.
12. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, and Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075-1082, 1995.
13. Konstan MW, Byard PJ, Hoppel CL, and Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332: 848-854, 1995.
14. Kube D, Adams L, Perez A, and Davis PB. Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. Am J Physiol Lung Cell Mol Physiol 280: L482-L492, 2001.
15. Ma J, Zhao J, Drumm M, Xie J, and Davis PB. Function of the R domain in the CFTR chloride channel. J Biol Chem 272: 28133-28141, 1997.
16. Massengale AR, Quinn F Jr, Yankaskas J, Weissman D, McClellan WT, Cuff C, and Aronoff SC. Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 20: 1073-1080, 1999.
17. Muhlebach MS, Stewart PW, Leigh MW, and Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160: 186-191, 1999.
18. Noah TL, Black HR, Cheng PW, Wood RE, and Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175: 638-647, 1997.
19. - cells in culture. Am J Physiol Lung Cell Mol Physiol 271: L85-L92, 1996.
20. Pier GB, Grout M, Zaidi TS, and Goldberg JB. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Crit Care Med 154: 5175-5182, 1996.
21. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, and Goldberg JB. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271: 64-67, 1996.
22. Rajan S, Cacalano G, Bryan R, Ratner AJ, Sontich CU, van Heeckeren A, Davis P, and Prince A. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of CFTR dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol 23: 304-312, 2000.
23. Saiman L and Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 92: 1875-1880, 1993.
24. Schwiebert LM, Estell K, and Propst SM. Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol Cell Physiol 276: C700-C710, 1999.
25. Smith JJ, Travis SM, Greenberg EP, and Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85: 1-20, 1996.
26. Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, Lichtenstein LM, and Schleimer RP. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol 155: 410-418, 1995.
27. Tabary O, Zahm JM, Hinnarsky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E, and Jacquot J. Selective upregulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 153: 921-930, 1998.
28. Tang H, Kays M, and Prince A. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immun 63: 1278-1285, 1995.
29. Tortorella C, Piazzolla G, Spaccavento F, and Antonaci S. Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis. Mediators Inflamm 7: 391-396, 1998.
30. Van Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB., and Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100: 2810-2815, 1997.
31. Zar H, Saiman L, Quittell L, and Prince A. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr 126: 230-233, 1995.